Boston Scientific Corp.'s profit drops by a third on acquisition costs

BOSTON (AP) - Boston Scientific Corp. said Tuesday its second-quarter profit fell by more than a third amid growing acquisition costs and moderating sales growth for its heart stents, but the medical-device maker matched Wall Street's expectations....More